Form 4: LENSAR CEO Nicholas Curtis Receives RSU Grant
Statement of Changes in Beneficial Ownership
LENSAR, Inc. CEO Nicholas T. Curtis was granted 130,662 restricted stock units as part of his compensation package.
Summary
- CEO Nicholas T. Curtis acquired 130,662 restricted stock units (RSUs) on June 3, 2026.
- The RSUs represent a contingent right to receive one share of common stock per unit.
- The grant vests in four substantially equal annual installments starting from the grant date.
- Following this transaction, the CEO's total beneficial ownership of common stock increased to 1,122,758 shares.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a routine administrative filing regarding executive compensation, which is neutral in terms of immediate market impact.
Positives
- The RSU grant aligns the CEO's long-term interests with those of shareholders through a four-year vesting schedule.
Negatives
- The issuance of additional equity units results in potential future dilution for existing shareholders.
Risks
- Vesting is contingent upon the Reporting Person's continued service to the Issuer, creating potential retention risk if the executive departs.
Future Outlook
The RSUs will vest in four equal annual installments, contingent on the CEO's continued service to the company.
Industry Context
StockSavvy.ai notes that equity-based compensation for C-suite executives is standard practice in the medical device sector to ensure leadership retention and alignment with long-term corporate performance.
Comparison to Industry Standards
- The use of four-year vesting schedules for executive equity grants is consistent with standard corporate governance practices for publicly traded companies in the U.S.
Stakeholder Impact
- Shareholders may experience minor dilution upon the eventual vesting and conversion of these RSUs into common stock.
Next Steps
- Vesting of the first installment of RSUs on the first anniversary of the grant date.
Key Dates
| Date | Description |
|---|---|
| 06/03/2026 | Date of the RSU grant transaction. |
| 06/05/2026 | Date the Form 4 was signed and filed. |
Keywords
LENSAR, LNSR, Form 4, Insider Trading, Executive Compensation, Restricted Stock Units
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.